DNA Synthesis Market Report 2026

The dna synthesis market size has grown exponentially in recent years. It will grow from $5.18 billion in 2025 to $6.25 billion in 2026 at a compound annual growth rate (CAGR) of 20.7%. The growth in the historic period can be attributed to limited availability of custom dna synthesis services, reliance on traditional solid-phase synthesis methods, growing r&d in biotechnology, increasing demand for diagnostics and therapeutics, adoption of gene synthesis for research.

The dna synthesis market size is expected to see exponential growth in the next few years. It will grow to $13.06 billion in 2030 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to technological advancements in automated dna synthesis platforms, rising applications in synthetic biology and gene therapy, expansion of cros and cdmos, increasing regulatory compliance and quality standards, integration of ai and bioinformatics in dna sequence design. Major trends in the forecast period include rising demand for custom dna sequences, growth in synthetic biology applications, increasing use of gene libraries for research, expansion of pcr-based and chip-based synthesis methods, focus on high-purity and accurate oligonucleotide production.

The growing demand for personalized medicine is anticipated to drive the expansion of the DNA synthesis market in the coming years. Personalized medicine is a healthcare approach that customizes treatment and prevention strategies based on an individual’s genetic makeup, lifestyle, and environmental factors to achieve optimal therapeutic outcomes. The rising demand for personalized medicine is largely fueled by advances in genomic technologies, which enable the development of treatments tailored to individual genetic profiles, thereby improving treatment effectiveness and reducing adverse effects. DNA synthesis plays a critical role in supporting personalized medicine by enabling the production of custom DNA sequences used in gene editing, diagnostic assays, and precision therapeutics, facilitating more accurate, efficient, and individualized healthcare solutions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based advocacy organization, the US Food and Drug Administration approved 16 new personalized treatments for patients with rare diseases in 2023, an increase from six approvals in 2022. Therefore, the increasing demand for personalized medicine is contributing to the growth of the DNA synthesis market.

Major companies operating in the DNA synthesis market are concentrating on the development of innovative technologies, such as synthetic deoxyribonucleic acid molecules, to enable faster, more precise, and cost-efficient creation of gene therapies, diagnostics, and synthetic biology solutions. Synthetic DNA molecules are laboratory-engineered nucleotide sequences designed to replicate or modify natural DNA for use in research, diagnostic, and biotechnological applications. For instance, in May 2025, Ribbon Biolabs, an Austria-based synthetic biology company, introduced MiroSynth, a new class of complex synthetic DNA molecules. This platform is designed to support high-throughput, automated, and scalable production of long and intricate DNA sequences for advanced biotechnology uses. MiroSynth offers features including high assembly accuracy, the ability to generate extended strand lengths, and rapid construction of complex genetic structures, making it suitable for research, therapeutic development, and industrial biotechnology. Its adaptable design allows seamless integration into diverse workflows, enabling researchers and developers to accelerate innovation across genomics, synthetic biology, and personalized medicine.

In February 2025, Maravai LifeSciences, a US-based life sciences company, acquired the DNA and RNA business of Officinae Bio for an undisclosed sum. This acquisition is intended to strengthen Maravai’s position in the nucleic acid manufacturing market by expanding its capabilities in high-quality DNA and RNA synthesis. Officinae Bio is an Italy-based biotechnology company specializing in the development and production of DNA and RNA for research and therapeutic applications.

Major companies operating in the dna synthesis market are GenScript Biotech Corporation, Twist Bioscience Corporation, Bioneer Corporation, DNA Script, Eton Bioscience, LGC Biosearch Technologies, Ansa Biotechnologies, Synbio Technologies, Quintara Biosciences, Elegen Corporation, Biomatik Corporation, Bio Basic Inc., Evonetix Ltd.

North America was the largest region in the DNA synthesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna synthesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dna synthesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the dna synthesis market by increasing the cost of imported reagents, enzymes, and synthesis equipment, impacting manufacturers’ production costs and supply chain efficiency. Segments such as custom gene synthesis and oligonucleotide synthesis are particularly affected, with regions like asia-pacific including china and india facing the highest import duties. While tariffs create pricing pressures and potential delays, they also encourage local manufacturing, innovation in reagent alternatives, and investment in domestic dna synthesis capabilities.

The dna synthesis market research report is one of a series of new reports that provides dna synthesis market statistics, including dna synthesis industry global market size, regional shares, competitors with a dna synthesis market share, detailed dna synthesis market segments, market trends and opportunities, and any further data you may need to thrive in the dna synthesis industry. This dna synthesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

DNA synthesis refers to the natural or laboratory-based process of producing a new strand of deoxyribonucleic acid. In living organisms, it occurs during cell division when DNA is replicated to transmit genetic information to daughter cells. In biotechnology, DNA synthesis also involves the chemical creation of customized DNA sequences within a laboratory setting.

The main service types of DNA synthesis include oligonucleotide synthesis, standard oligonucleotide synthesis, custom oligonucleotide synthesis, gene synthesis, custom gene synthesis, and gene library synthesis. Oligonucleotide synthesis is a chemical technique used to produce short nucleotide sequences, known as oligonucleotides, which are widely applied in genetic testing, research, diagnostics, and therapeutic development. Various methods are used for this process, including solid-phase synthesis, PCR-based enzymatic synthesis, and chip-based synthesis. These services support multiple applications such as research and development, diagnostics, therapeutics, synthetic biology, and others, and are utilized by key end users including pharmaceutical and biotechnology companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), academic and research institutions, and others.

The DNA synthesis market consists of revenues earned by entities by creating synthetic DNA sequences for use in research, diagnostics, therapeutics, and biotechnology applications. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA synthesis market includes sales of custom DNA oligonucleotides, gene synthesis kits, reagents, and associated synthesis tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.